BR100 Increased By (0.12%)
BR30 Increased By (0.28%)
KSE100 Increased By (0.26%)
KSE30 Increased By (0.26%)
AGHA 7.63 Increased By ▲ 0.04 (0.53%)
BECO 5.57 Increased By ▲ 0.06 (1.09%)
BML 59.74 Increased By ▲ 0.66 (1.12%)
BOP 34.40 Increased By ▲ 0.29 (0.85%)
CNERGY 13.11 Increased By ▲ 0.27 (2.1%)
CSIL 6.41 Increased By ▲ 0.31 (5.08%)
FCCL 58.06 Increased By ▲ 0.40 (0.69%)
FFL 16.23 Increased By ▲ 0.03 (0.19%)
FNEL 1.21 No Change ▼ 0.00 (0%)
KEL 7.43 Decreased By ▼ -0.05 (-0.67%)
KOSM 6.03 Increased By ▲ 0.09 (1.52%)
LOTCHEM 27.67 Decreased By ▼ -0.32 (-1.14%)
MLCF 102.75 Increased By ▲ 2.10 (2.09%)
NBP 205.06 Increased By ▲ 1.31 (0.64%)
NCPL 59.63 Decreased By ▼ -0.94 (-1.55%)
NPL 68.56 Decreased By ▼ -1.40 (-2%)
OGDC 318.92 Decreased By ▼ -1.37 (-0.43%)
PACE 11.05 Decreased By ▼ -0.05 (-0.45%)
PAEL 43.10 Decreased By ▼ -0.02 (-0.05%)
PIBTL 16.63 Increased By ▲ 0.07 (0.42%)
PPL 229.45 Increased By ▲ 0.61 (0.27%)
PRL 70.80 Decreased By ▼ -0.22 (-0.31%)
PTC 71.00 Decreased By ▼ -0.65 (-0.91%)
SSGC 27.41 Increased By ▲ 0.73 (2.74%)
TBL 10.31 Increased By ▲ 0.50 (5.1%)
TELE 8.53 Decreased By ▼ -0.08 (-0.93%)
TPL 23.06 Increased By ▲ 0.82 (3.69%)
TPLP 15.76 Increased By ▲ 0.65 (4.3%)
TREET 24.71 Increased By ▲ 0.58 (2.4%)
TRG 60.29 Increased By ▲ 0.45 (0.75%)

KARACHI: Pharmaceutical companies in Pakistan should invest in research and development and adopt patents and licenses from multinational companies to bring the impetus to the growth of drug production across the country.

Addressing a seminar on "Intellectual Property Right, Patents, Copy write and Design" held at the 20th Pharma Asia Conference, Deputy Director at IPO Pakistan Syed Ali Mohammad Zaidi said adoption of patents in the pharmaceutical sector has a crucial role in its sustainable growth and expansion; however, a producer of medicine needs to invest on research and development. He urged pharmaceutical companies to invest in research, development and patents to have more share in the overall pie of sales and productions of the market.

Tajammul Haider, former focal person to WIPO (Geneva), said distribution companies of various products, mainly the pharmaceutical sector, should avail of the licenses from multinational companies to enhance the local production of the medicine. He added that the licensing regime will reduce the country's import bill and ensure the availability of medicine at the domestic level while enhancing the staff member's capacity. He said the need for more awareness in the export-oriented companies could not focus on these core issues; however, the government should encourage exporters to bring new technologies into the country.

Haider mentioned that WIPO systems have received a healthy response from foreign companies to get applications 18,000 for their registration and patents in Pakistan. In contrast, a few Pakistani companies made less attempts of filing application process. He urged universities and chambers of commerce to enlighten students and traders about patents, intellectual property rights, etc, to build an understanding of the importance of these topics.

Pakistan's pharmaceutical industry is a significant contributor to the economy, with an estimated value of $ 3.2 billion and a growth rate of around 15% annually.

Copyright Business Recorder, 2023

Comments

Comments are closed for this article.